Lentiviral vectors containing an MHC class I promoter

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8951535
APP PUB NO 20140120132A1
SERIAL NO

13873922

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to the insertion of a promoter sequence from an MHC class I gene promoter into a lentiviral vector in order to direct the transcription of a transgene, which preferably encodes an immunogenic polypeptide to be expressed in a mammalian cell host, preferably APC (DCs). The invention encompasses these vectors, methods of making the vectors, and methods of using them, including medicinal uses.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THERAVECTYSBATIMENT PASTEUR BIOTOP 28 RUE DU DOCTEUR ROUX PARIS F-75015

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bauche, Cecile Paris, FR 16 31
Sarry, Emeline Malakoff, FR 8 4

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 10, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00